Barclays Cuts Revance Therapeutics (NASDAQ:RVNC) Price Target to $3.00
Revance Therapeutics (NASDAQ:RVNC – Free Report) had its price target trimmed by Barclays from $7.00 to $3.00 in a research note issued to investors on...
HashiCorp (NASDAQ:HCP) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of HashiCorp (NASDAQ:HCP – Free Report) in a report released on Monday morning. The firm issued a hold rating on...
NortonLifeLock (NASDAQ:NLOK) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of NortonLifeLock (NASDAQ:NLOK – Free Report) in a report published on Monday morning. The brokerage issued a buy rating on...
Rockwell Medical’s (RMTI) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Rockwell Medical (NASDAQ:RMTI – Free Report) in a report issued on Monday morning,Benzinga reports. HC Wainwright...
FingerMotion Announces Closing of $5.0 Million Registered Direct OfferingSingapore / NEWSFILE / December 23, 2024 / FingerMotion, Inc. (NASDAQ: FNGR) announced the successful completion of its registered direct offering. The offering comprised 3,333,
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read FingerMotion’s 8K...
Arcadium Lithium (NYSE: ALTM) Shareholders Approve Rio Tinto Transaction
Arcadium Lithium plc (NYSE: ALTM) recently held special meetings with its shareholders, resulting in the approval of a proposed transaction with Rio Tinto BM Subsidiary...